Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-22

Clinical Trial Update: Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effects of metformin on gut peptides, bile acids, and lipid profiles in adults with Type 2 diabetes mellitus; the study st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED